Sheeja Aravindan

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (47)

• Abstract 2074: Bioactive marine drugs target acquired oncogenic burden in resilient pancreatic cancer
  Experimental and Molecular Therapeutics 2019 DOI: 10.1158/1538-7445.sabcs18-2074
  +Save
• Abstract 2074: Bioactive marine drugs target acquired oncogenic burden in resilient pancreatic cancer
  Experimental and Molecular Therapeutics 2019 DOI: 10.1158/1538-7445.am2019-2074
  +Save
• Abstract 2874:De novoacquisition of RD3 loss with intensive multi-modal therapy harmonize neuroblastoma relapse
  Tumor Biology 2019 DOI: 10.1158/1538-7445.sabcs18-2874
  +Save
• Abstract 2874:De novoacquisition of RD3 loss with intensive multi-modal therapy harmonize neuroblastoma relapse
  Tumor Biology 2019 DOI: 10.1158/1538-7445.am2019-2874
  +Save
• Targeting acquired oncogenic burden in resilient pancreatic cancer: a novel benefit from marine polyphenols
  Molecular and Cellular Biochemistry 2019 DOI: 10.1007/s11010-019-03579-8
  +Save
• Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples
  BMC Cancer 2019 DOI: 10.1186/s12885-019-5306-0
  +Save
• De novo regulation of RD3 synthesis in residual neuroblastoma cells after intensive multi-modal clinical therapy harmonizes disease evolution
  Scientific Reports 2019 DOI: 10.1038/s41598-019-48034-2
  +Save
• Abstract 2082: High-throughput droplet digital PCR for MYCN amplification detection in FFPE neuroblastoma samples: Cost-effective, rapid, feasible, and reliable alternative to FISH
  Tumor Biology 2018 DOI: 10.1158/1538-7445.am2018-2082
  +Save
• Retinal Degeneration Protein 3 (RD3) in normal human tissues: Novel insights
  Scientific Reports 2017 DOI: 10.1038/s41598-017-13337-9
  +Save
• Abstract 5211:Hormophysa triquertapolyphenol, an elixir that deters CXCR4- and COX2-dependent dissemination destiny of treatment-resistant pancreatic cancer cells
  Experimental and Molecular Therapeutics 2017 DOI: 10.1158/1538-7445.am2017-5211
  +Save